Authors
Latest:
Unmet Needs in Diffuse Large B-Cell LymphomaAndre H. Goy, MD, and Andrew Ip, MD, offer closing remarks on unmet needs in the treatment of diffuse large B-cell lymphoma.
Latest:
POINT-Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?Quality of life is better after modern radiotherapy compared with surgery.
Latest:
Breast Lesion in Patient With HIVA 41-year-old woman with a past medical history notable for HIV underwent her first screening mammogram, which demonstrated a 1.5-cm irregular focal asymmetry in the left breast. What is your diagnosis?
Latest:
Hypofractionated Regimen Safe, Feasible in Elderly Bladder Cancer PatientsIn this interview we discuss results of the HYBRID trial, which tested a hypofractionated regimen of 36 Gy over six fractions in elderly muscle-invasive bladder cancer patients who were ineligible for standard treatments.
Latest:
ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation TherapyThis peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.
Latest:
ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation TherapyThis peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.
Latest:
Endings & Beginnings-Grief, Loss, and Letting GoAs an oncology health care provider, it is crucially important to process grief and loss in order to best care for yourself and your patients.
Latest:
Risk of AML in Thyroid Cancer Patients Treated With Radioactive IodineIn this interview we discuss a study that examined the risk of acute myeloid leukemia in thyroid cancer patients who have been treated with surgery and radioiodine therapy vs those treated with surgery alone.
Latest:
ColoScape Assay Can Detect Recurrence in Colorectal Cancer PatientsIn this interview, we discuss an assay that can detect disease recurrence in colorectal cancer patients.
Latest:
Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular MarkersIn this article, we discuss the requirements for development and validation of urine markers and the factors that hamper their clinical implementation. We also review current surveillance guidelines for NMIBC and provide an overview of approved urine markers for the detection and surveillance of NMIBC.
Latest:
Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular MarkersIn this article, we discuss the requirements for development and validation of urine markers and the factors that hamper their clinical implementation. We also review current surveillance guidelines for NMIBC and provide an overview of approved urine markers for the detection and surveillance of NMIBC.
Latest:
SIO President Lynda Balneaves Hopes to Continue Work on Expanding the Society’s ReachIn this interview we discuss the goals of SIO, the response to donations intended for interdisciplinary integrative health, and how palliative care and psychosocial oncology can enhance each other.
Latest:
Emergence of a Novel Staging System for Oropharyngeal Squamous Cell Carcinoma Based on HPV StatusThe staging of oropharyngeal squamous cell carcinoma has undergone key changes in the eighth edition of the American Joint Committee on Cancer Staging Manual, set to take effect January 1, 2018. We describe the revised staging parameters and the rationale in support of the changes.
Latest:
Emergence of a Novel Staging System for Oropharyngeal Squamous Cell Carcinoma Based on HPV StatusThe staging of oropharyngeal squamous cell carcinoma has undergone key changes in the eighth edition of the American Joint Committee on Cancer Staging Manual, set to take effect January 1, 2018. We describe the revised staging parameters and the rationale in support of the changes.
Latest:
Emergence of a Novel Staging System for Oropharyngeal Squamous Cell Carcinoma Based on HPV StatusThe staging of oropharyngeal squamous cell carcinoma has undergone key changes in the eighth edition of the American Joint Committee on Cancer Staging Manual, set to take effect January 1, 2018. We describe the revised staging parameters and the rationale in support of the changes.
Latest:
Radiation Dermatitis: Recognition, Prevention, and ManagementThis article highlights the typical skin reactions associated with RT, as well as current evidence-based approaches to management and intervention.
Latest:
Radiation Dermatitis: Recognition, Prevention, and ManagementThis article highlights the typical skin reactions associated with RT, as well as current evidence-based approaches to management and intervention.
Latest:
Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?A previously healthy 36-year-old man initially presented to his primary care physician with occasional bloody stools and dull right upper quadrant pain. Blood was sometimes mixed into his stools but was more often seen on the toilet paper after wiping.
Latest:
Optimizing Treatment Approaches in Advanced Renal CancerThis article provides a practical perspective on the management of advanced RCC, as well as insight into the current models of risk stratification and ongoing clinical trials. The discussion will focus on the currently available systemic therapies; other strategies that are beyond the scope of this article include active surveillance and metastasectomy.
Latest:
1L Treatment Landscape for Advanced Renal Cell CarcinomaPanelists discuss how the evolving first-line treatment landscape for advanced renal cell carcinoma is shaped by novel immunotherapy combinations, including lenvatinib plus pembrolizumab, and the impact of these therapies on patient outcomes and progression patterns.
Latest:
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing OutcomesIn those with DLBCL, Burkitt lymphoma, and Hodgkin lymphoma, cure is often achieved. Furthermore, in the salvage setting, whether auto-HCT or allo-HCT is used, the same appears to be true. A great deal of progress has been made in the treatment of lymphoma in patients with HIV infection, but more remains to be done before outcomes are comparable to those of the general population.
Latest:
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing OutcomesIn those with DLBCL, Burkitt lymphoma, and Hodgkin lymphoma, cure is often achieved. Furthermore, in the salvage setting, whether auto-HCT or allo-HCT is used, the same appears to be true. A great deal of progress has been made in the treatment of lymphoma in patients with HIV infection, but more remains to be done before outcomes are comparable to those of the general population.
Latest:
Adding Nivolumab to Induction Chemotherapy Safe in Younger AML PatientsThis video highlights a phase II trial that tested the addition of nivolumab to combination induction chemotherapy of cytarabine and idarubicin for patients with newly diagnosed acute myeloid leukemia.
Latest:
Skin Lesions in Patient With Metastatic Breast CancerA 57-year-old woman with metastatic HER2/neu-positive breast cancer started treatment with a combination of docetaxel, pertuzumab, and trastuzumab. On the fourth cycle the patient complained of mild irritation and a skin rash on her left upper extremity. What is your diagnosis?
Latest:
Is Molecular Remission the Goal When Treating Myeloma?In this interview we discuss the goals of therapy in multiple myeloma, treatment combinations and transplantation, and how markers such as minimal residual disease are used.
Latest:
DLBCL Trials May Exclude Patients Who Need Novel Therapies MostIn this interview we discuss how a short diagnosis-to-treatment interval in newly diagnosed diffuse large B-cell lymphoma is associated with worse outcomes and how this could lead to trials favoring patients with a longer diagnosis-to-treatment interval and better expected outcomes.
Latest:
Precision Imaging in Breast CancerThis video highlights four posters from SABCS on the use of mammography, magnetic resonance imaging, and radiomics as biomarkers for treatment response.
Latest:
Clinical Pearls for Community Oncologists Treating MyelofibrosisThe panel closes their discussion on myelofibrosis treatment updates by sharing clinical pearls for community oncologists.
Latest:
Preventing, Treating Relapse After ASCT in Hematologic Malignancy PatientsThis video highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation.
Latest:
Identifying Children With Leukemia Predisposition SyndromesThis video reviews classic syndromes associated with increased leukemia susceptibility and highlights pediatric patients who may be at increased risk for an inherited leukemia predisposition and should receive additional work-up.
